-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

323.O1.6 323. Disorders of Coagulation, Bleeding, or Fibrinolysis, Excluding Congenital Hemophilias: Clinical and Epidemiological: Novel Treatments and Outcomes

Symposia: Disorders of Coagulation, Bleeding, or Fibrinolysis, Excluding Congenital Hemophilias: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Bleeding and Clotting, Bleeding disorders, Adult, Combination therapy, Epidemiology, Hemophilia, Elderly, Clinical Research, Genetic Disorders, Platelet disorders, Health outcomes research, Pediatric, Diseases, Real-world evidence, Treatment Considerations, Pregnant, Registries, VWD, Young adult , Adverse Events, Biological Processes, Study Population, Human, Pathogenesis, Maternal Health
Sunday, December 8, 2024: 12:00 PM-1:30 PM
Room 29 (San Diego Convention Center)
Moderators:
Shreya Agarwal, MD, Benioff Children's Hospital/University of California San Francisco and Suchitra Acharya, MD, Cohen Children's Medical Center of New York
Disclosures:
No relevant conflicts of interest to declare.

This was the single session from category 323 so that it ended up containing all top-ranked abstracts, with no specific theme aside from that of the main category. Since the six abstracts address either novel treatments or clinically-relevant outcomes of specific populations, the theme that could be identified was this one (Novel treatments and outcomes).
12:00 PM

Hanny Al-Samkari, MD1,2, Josefien Hessels, MD3*, Antoni Riera-Mestre, MD4*, Sophie Dupuis-Girod, MD5*, Thibaut Van Zele, MD6*, Vincente Gómez del Olmo, MD7*, Pierre Saint-Mezard, PhD8*, Hedvika Lazar, MSc, MPH8*, Damien Picard, MD8*, Debra Barker, MD8*, Elisabetta Buscarini, MD9* and Hans-Jurgen Mager, MD3*

1Harvard Medical School, Boston, MA
2Division of Hematology Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
3St. Antonius Hospital, Nieuwegein, Netherlands
4HHT Unit, Internal Medicine Department, Hospital Universitari de Bellvitge, Barcelona, Spain
5Femme-Mère-Enfants Hospital, Hospices Civils de Lyon, Lyon, France
6Upper Airways Research Laboratory, Ghent University Hospital, Ghent, Belgium
7Internal Medicine Department, Hospital Universitario Ramón y Cajal, Madrid, Spain
8Vaderis Therapeutics AG, Basel, Switzerland
9HHT Reference Center ERN, Ospedale Maggiore, ASST Crema, Crema, Italy

12:15 PM

Ellen Cusano, MD1, Julia Hews-Girard, RN PhD2*, Mujtaba Basharat, BSc3*, Lindsay Cowley, MA4*, Julie Grabell5*, Nancy Hodgson6*, Kelly Pittman, RN BN MN7*, Allison Rupnaraine8*, Rowan Thillaye-Kerr8*, Brendan Cord Lethebe9*, Paula James, MD, FRCPC10, Roy Khalife, MD, MHPE, FRCPC4,11, Natasha Pardy, MD, FRCPC12*, Chai W. Phua, MD, FRCPC3, Oksana C. Prokopchuk-Gauk, MD FRCPC DRCPSC13, Michelle Sholzberg, MD, M.Sc14, Haowei Linda Sun, MD MHSc FRCPC15, Man-Chiu Poon, MD16 and M. Dawn Goodyear, MD, MSc17

1Center for Bleeding and Clotting Disorders, University of California San Diego, San Diego, CA
2Faculty of Nursing, University of Calgary, Calgary, AB, Canada
3Department of Medicine, Division of Hematology, Western University, London, ON, Canada
4Ottawa Hospital Research Institute, Ottawa, ON, Canada
5Department of Medicine, Queen's University, Kingston, ON, Canada
6University of Saskatchewan, Clinical Trial Support Unit, Saskatoon, SK, Canada
7Division of Clinical Research, Newfoundland and Labrador Health Services, St. John’s, NF, Canada
8Hematology Oncology Clinical Research Group, St. Michael’s Hospital, Toronto, ON, Canada
9Clinical Research Unit, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
10Division of Hematology, Department of Medicine, Queen's University, Kingston, ON, Canada
11Department of Medicine, University of Ottawa, The Ottawa Hospital, Ottawa, ON, Canada
12Division of Hematology, Eastern Health, St. John's, NF, Canada
13University of Saskatchewan, Department of Pathology and Lab Medicine, Saskatoon, SK, Canada
14Departments of Medicine, and Laboratory Medicine and Pathobiology, St. Michael’s Hospital, Li Ka Shing Knowledge Institute, University of Toronto, Toronto, ON, Canada
15Division of Hematology, Department of Medicine, University of Alberta, Edmonton, AB, Canada
16Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
17Department of Medicine, Division of Hematology and Hematological Malignancies, University of Calgary, Calgary, AB, Canada

12:30 PM

Inga M. Schimansky, MD1*, Andreas Tiede, MD2, Christiane Dobbelstein2*, Dr. Robert Klamroth3*, Christina Hart, MD4*, Ulrich J. Sachs, MD, PhD5*, Richard Greil, MD6, Paul N. Knöbl, MD7*, Johannes Oldenburg, MD8, Christian Pfrepper, MD9*, Karolin Trautmann-Grill10*, Patrick Moehnle11*, Katharina Holstein12* and Wolfgang A. Miesbach, MD, PhD13*

1Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
2Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
3Vivantes Klinikum im Friedrichshain, Berlin, Berlin, Germany
4Medical Clinic III, University Hospital Regensburg, Regensburg, Germany
5Institute for Clinical Immunology, Transfusion Medicine, and Haemostasis, Justus Liebig University Giessen, Giessen, Germany
6Paracelsus Medical University, Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Salzburg, Austria
7Division of Hematology and Hemostasis, Department of Medicine I, Medical University of Vienna, Vienna, Austria
8Institute for Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany
9Division of Hemostaseology, Medical Department I, University Hospital Leipzig, Leipzig, Germany
10University Hospital Carl Gustav Carus, Dresden, Germany
11Department of Transfusion Medicine, Cellular Therapeutics and Hemostaseology, Department of Anesthesiology,, Hospital of Ludwig Maximilian University, Munich, Germany, Muenchen, DEU
12Hematology and Oncology,, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, Hamburg, DEU
13University Hospital, Haemophilia Ctr., Frankfurt, Germany

12:45 PM

Lauren E. Amos, MD MS1, Hung-Wen Yeh, Phd1*, Ayesha Zia, MD, MSc2, Meera Chitlur, MD3, Lynn Malec, MD MSc4* and Allison P. Wheeler, MD5

1Children's Mercy Kansas City, Kansas City, MO
2University of Texas Southwestern Medical Center, Dallas, TX
3Central Michigan University, Carmen and Ann Adams Department of Pediatrics, Children's Hospital of Michigan, Detroit, MI
4Versiti Blood Research Institute, Milwaukee, WI, US; Department of Medicine and Pediatrics, Division of Hematology/Oncology, Medical College of Wisconsin, WI, US, Milwaukee, WI
5Washington Center for Bleeding Disorders, Seattle, WA

1:00 PM

Wolfgang Korte, MD1, Justus Bürgi, PhD2* and Christian Haslinger, MD3*

1Hemostasis and Hemophilia Center, Center For Laboratory Medicine St. Gallen, St. Gallen, Switzerland
2Hemostasis and Hemophilia Center, Center for Laboratory Medicine, St. Gallen, Switzerland
3Department of Obstetrics, University Hospital Zürich, Zurich, CHE

1:15 PM

Ellen Zhang, MD1, Pamela G Hodges, PhD, ANP2*, Josanna Rodriguez-Lopez, MD3,4* and Hanny Al-Samkari, MD2,4

1Department of Medicine, Stanford University Medical Center, Palo Alto, CA
2Division of Hematology Oncology, Massachusetts General Hospital, Boston, MA
3Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA
4Harvard Medical School, Boston, MA

*signifies non-member of ASH